Warner-Chilcott Back On The Block: Buy-Out Offer Values Firm At $2.7 Bil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Private equity group has approached company about possible bid. Proposal comes a year after Warner-Chilcott/Galen held negotiations with another pharma company about a merger.